12:00 AM
 | 
Dec 21, 2009
 |  BC Week In Review  |  Clinical News  |  Clinical Results

ON 01910: Phase I/II data

Data from a dose-escalation Phase I/II trial in 13 evaluable patients showed that a weekly 48-hour continuous IV infusion of ON 01910.Na for 3 weeks of a...

Read the full 115 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >